During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA).
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study / Cauli, A., Gladman, D.D., Mathieu, A., Olivieri, I., Porru, G., Tak, P.P., Sardu, C., Ujfalussy, I., Scarpa, R., Marchesoni, A., Taylor, W.J., Spadaro, A., Fernàndez Sueiro, J.L., Salvarani, C., Kalden, J.R., Lubrano, E., Carneiro, S., Desiati, F., Flynn, J.A., D'Angelo, S., et al.. - In: THE JOURNAL OF RHEUMATOLOGY. - ISSN 0315-162X. - 38:5(2011), pp. 898-903. [10.3899/jrheum.100857]
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study
SALVARANI, CARLO;
2011
Abstract
During OMERACT 8, delegates selected patient global assessment (PGA) of disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). This study assessed the reliability of the PGA, measured by means of 0-100 mm visual analog scale (VAS), and the additional utility of separate VAS scales for joints (PJA) and skin (PSA).
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
